Why 10x Genomics is on investors’ radar today 10x Genomics (TXG) has drawn fresh attention after recent trading, with the ...

Pleasanton, Calif.-based biotechnology startup 10x Genomics went public on Sept. 12, opening on the Nasdaq Stock Market at a price of $39 per share. The company’s initial public offering price was ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q3 CY2025 results , but sales fell by 1.7% year on year to $149 million. On top of that, next quarter’s revenue guidance ($156 million at the ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 4.7% in the afternoon session after the company announced weak preliminary results for its fourth quarter and full year 2025, ...

10x Genomics (TXG) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

That occurred on Monday, when Tejas Savant from white-shoe investment bank Morgan Stanley reduced his 10x Genomics price target to $18 per share, far down from his previous level of $26. Despite that, ...